Double Trouble: Clinical and Psychological Characteristics in SCAD With and Without Fibromuscular Dysplasia

Lisa-Marie Maukel1, Laurie-Anne Boivin-Proulx1, Jacqueline Saw2

  • 1University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

JACC. Advances
|June 18, 2026
PubMed

Insights

Spontaneous coronary artery dissection (SCAD) patients with fibromuscular dysplasia (FMD) are older, more often female, and experience higher psychological distress. Early screening for FMD and psychological support is crucial for this subgroup.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Psychology

Background:

  • Spontaneous coronary artery dissection (SCAD) is a significant cause of acute coronary syndrome, primarily affecting women and often linked to substantial psychological distress.
  • Fibromuscular dysplasia (FMD), a nonatherosclerotic vascular disorder, frequently co-occurs with SCAD, complicating clinical management and potentially intensifying patient distress.
  • Limited research exists on the specific patient characteristics differentiating SCAD patients with and without co-occurring FMD.

Purpose of the Study:

  • To compare the demographic, clinical, and psychological profiles of SCAD patients diagnosed with and without fibromuscular dysplasia.
  • To identify distinct characteristics associated with SCAD patients who also have FMD.
  • To understand the impact of a co-occurring FMD diagnosis on psychological distress in SCAD patients.

Main Methods:

  • A multicenter study involving SCAD patients diagnosed within the last three years.
  • Chart review for medical data, including screening for FMD, and completion of sociodemographic questionnaires.
  • Administration of validated psychological measures: Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Cardiac Anxiety Questionnaire (CAQ), and PTSD Checklist-5 (PCL-5).

Main Results:

  • Of 326 participants, 128 (43.2%) met diagnostic criteria for FMD after screening.
  • SCAD patients with FMD were older, more frequently female, and reported a higher incidence of migraines compared to those without FMD.
  • Among patients aware of their FMD diagnosis, significantly higher rates of depression (32.8% vs 20.8%), anxiety (31.3% vs 17.4%), cardiac anxiety (64.2% vs 49.2%), and post-traumatic stress (25.4% vs 11.6%) were observed (all P < 0.05).

Conclusions:

  • SCAD patients with a concomitant FMD diagnosis present with unique characteristics and report significantly elevated psychological distress.
  • The findings underscore the necessity for early and comprehensive screening for both FMD and psychological distress in SCAD patients.
  • Anticipatory psychological support and tailored interventions are recommended for SCAD patients with FMD due to the potential for increased psychological burden associated with the FMD diagnosis.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...